BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 20223228)

  • 1. Combination of aspirin with telmisartan suppresses the augmented TGFbeta/smad signaling during the development of streptozotocin-induced type I diabetic nephropathy.
    Mulay SR; Gaikwad AB; Tikoo K
    Chem Biol Interact; 2010 Apr; 185(2):137-42. PubMed ID: 20223228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with spironolactone and candesartan protects against streptozotocin-induced diabetic nephropathy in rats.
    Hofni A; El-Moselhy MA; Taye A; Khalifa MM
    Eur J Pharmacol; 2014 Dec; 744():173-82. PubMed ID: 25446917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways.
    Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual therapy versus monotherapy of trandolapril and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats.
    Rao RP; Jain A; Srinivasan B
    J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):169-75. PubMed ID: 21421651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combined strategy with PPARα agonism and AT₁ receptor antagonism is not superior relative to their individual treatment approach in preventing the induction of nephropathy in the diabetic rat.
    Bishnoi HK; Mahadevan N; Balakumar P
    Pharmacol Res; 2012 Oct; 66(4):349-56. PubMed ID: 22796657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of telmisartan with sildenafil ameliorate progression of diabetic nephropathy in streptozotocin-induced diabetic model.
    El-Mahdy NA; El-Sayad ME; El-Kadem AH
    Biomed Pharmacother; 2016 Jul; 81():136-144. PubMed ID: 27261587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DPP-4 inhibition on top of angiotensin receptor blockade offers a new therapeutic approach for diabetic nephropathy.
    Alter ML; Ott IM; von Websky K; Tsuprykov O; Sharkovska Y; Krause-Relle K; Raila J; Henze A; Klein T; Hocher B
    Kidney Blood Press Res; 2012; 36(1):119-30. PubMed ID: 23171828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual therapy of vildagliptin and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats.
    Sharma AK; Kanawat DS; Mishra A; Dhakad PK; Sharma P; Srivastava V; Joshi S; Joshi M; Raikwar SK; Kurmi MK; Srinivasan BP
    J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):410-8. PubMed ID: 23396552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive effects of rutin on the development of experimental diabetic nephropathy in rats.
    Hao HH; Shao ZM; Tang DQ; Lu Q; Chen X; Yin XX; Wu J; Chen H
    Life Sci; 2012 Nov; 91(19-20):959-67. PubMed ID: 23000098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-β/smad and ERK1/2 signaling in streptozotocin-induced diabetic rats.
    Chen KH; Hung CC; Hsu HH; Jing YH; Yang CW; Chen JK
    Chem Biol Interact; 2011 Mar; 190(1):45-53. PubMed ID: 21300041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway.
    Kolati SR; Kasala ER; Bodduluru LN; Mahareddy JR; Uppulapu SK; Gogoi R; Barua CC; Lahkar M
    Environ Toxicol Pharmacol; 2015 Mar; 39(2):690-9. PubMed ID: 25704036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursolic acid improves diabetic nephropathy via suppression of oxidative stress and inflammation in streptozotocin-induced rats.
    Xu HL; Wang XT; Cheng Y; Zhao JG; Zhou YJ; Yang JJ; Qi MY
    Biomed Pharmacother; 2018 Sep; 105():915-921. PubMed ID: 30021385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression.
    Alhaider AA; Korashy HM; Sayed-Ahmed MM; Mobark M; Kfoury H; Mansour MA
    Chem Biol Interact; 2011 Jul; 192(3):233-42. PubMed ID: 21457706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of oxidative stress and inflammatory cytokines induces apoptosis in diabetic nephropathy.
    Sha J; Sui B; Su X; Meng Q; Zhang C
    Mol Med Rep; 2017 Nov; 16(5):7715-7723. PubMed ID: 28944839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telmisartan ameliorates germ cell toxicity in the STZ-induced diabetic rat: studies on possible molecular mechanisms.
    Kushwaha S; Jena GB
    Mutat Res; 2013 Jul; 755(1):11-23. PubMed ID: 23648321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telmisartan attenuates diabetic nephropathy by suppressing oxidative stress in db/db mice.
    Sato-Horiguchi C; Ogawa D; Wada J; Tachibana H; Kodera R; Eguchi J; Nakatsuka A; Terami N; Shikata K; Makino H
    Nephron Exp Nephrol; 2012; 121(3-4):e97-e108. PubMed ID: 23307263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action.
    Lakshmanan AP; Watanabe K; Thandavarayan RA; Sari FR; Harima M; Giridharan VV; Soetikno V; Kodama M; Aizawa Y
    Free Radic Res; 2011 May; 45(5):575-84. PubMed ID: 21381899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Danshen injection ameliorates STZ-induced diabetic nephropathy in association with suppression of oxidative stress, pro-inflammatory factors and fibrosis.
    Xu L; Shen P; Bi Y; Chen J; Xiao Z; Zhang X; Wang Z
    Int Immunopharmacol; 2016 Sep; 38():385-94. PubMed ID: 27355131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Febuxostat ameliorates diabetic renal injury in a streptozotocin-induced diabetic rat model.
    Lee HJ; Jeong KH; Kim YG; Moon JY; Lee SH; Ihm CG; Sung JY; Lee TW
    Am J Nephrol; 2014; 40(1):56-63. PubMed ID: 25034030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration.
    Navarro JF; Milena FJ; Mora C; León C; García J
    Am J Nephrol; 2006; 26(6):562-70. PubMed ID: 17167242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.